SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...
Billingham, Teesside, UK and Research Triangle Park, NC, USA, August 19, 2014 / B3C newswire / - FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing ...
SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 / Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major ...
FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreactors. One each of these is being ...
Entertain Hybrid Approaches and Comprehensive Views of Process Analytics, Automation, and Quality Assurance Whoever said there’s nothing new under the sun was not, evidently, referring to bioreactors.
Recent Survey Finds Commercial-Stage Use of Disposables Continuing on Upward Trajectory Bioreactors are constantly evolving, with improvements being introduced rapidly. To assess how the industry will ...
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors. Scale-up (and down) modeling of bioreactors is a valuable tool to support process characterization and improvement in a ...
LONDON, Nov. 27, 2014 /PRNewswire/ -- INTRODUCTIONThere is widespread optimism that the single-use bioreactors market is likely to continue its double digit growth in the future. The concept of ...
WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results